Pandora Wealth’s Bionano Genomics BNGO Stock Holding History

Pandora Wealth’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3	Closed	-$10	–	235
2025 Q2	$10	Hold	3	–	–	﹤0.01%	296
2025 Q1	$8	Buy	+3	New	+$20	﹤0.01%	264

Other funds holding BNGO

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CAM

Carret Asset Management New York $1.02B AUM 26.95% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pandora Wealth's BNGO Position: Q3 2025 in Review

Pandora Wealth sold out of Bionano Genomics (BNGO) in Q3 2025, closing a stake of 3 shares — an estimated $10 sold.

Pandora Wealth first reported a position in BNGO in Q1 2025 and held it in 2 quarters. The position peaked at $10 in Q2 2025. 32 funds tracked by Wall St. Rank hold BNGO as of Q3 2025.

Pandora Wealth reported no remaining Bionano Genomics position as of Q3 2025 after selling out during the quarter.
Pandora Wealth sold 3 Bionano Genomics shares in Q3 2025, an estimated $10.
Pandora Wealth first reported a position in Bionano Genomics in Q1 2025 and held it in 2 quarters.
Pandora Wealth's Bionano Genomics position peaked at $10 in Q2 2025.
32 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2025.

Based on Pandora Wealth's 13F filing for Q3 2025, filed 3 Nov 2025.